Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome. Posted on 10 Febbraio 201510 Febbraio 2020 by admin Rosa GM, Ferrero S, Nitti VW, Wagg A, Saleem T, Chapple CR. Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome.Eur Urol 2016;69:311-23.https://www.europeanurology.com/article/S0302-2838(15)00864-7/fulltext